Entering text into the input field will update the search result below

Beyond Air: Buy The Stock Ahead Of March 5 Analyst Day

Mar. 03, 2020 4:34 PM ETBeyond Air, Inc. (XAIR)LIN, MNKTQ13 Comments
Revere Investing profile picture
Revere Investing


  • Beyond Air’s first-ever analyst day, to be held March 5, will highlight the value of its LungFit nitric oxide (NO) platform and the potential of its clinical pipeline.
  • LungFit PH (pulmonary hypertension) Pre Market Approval (PMA) submission is expected to be completed around the end of April and is on track for a 4Q20 launch.
  • LungFit BRO (bronchiolitis) pilot study enrollment is expected to be completed by the end of February with data reported around midyear.
  • LungFit NTM (non-tuberculous mycobacteria) proof of concept (POC) study will be initiated to evaluate its at-home program around midyear.
  • Coronavirus (COVID-19) highlights the need for novel therapies for the treatment of bacterial and viral lung infections.

Beyond Air (NASDAQ:XAIR) is a medical device and biopharmaceutical company that is developing LungFit, a portable nitric oxide (NO) generator and delivery system that generates NO from ambient air. NO was approved for persistent pulmonary hypertension of the newborn (PPHN) in the U.S. by the FDA in 1999 and for PPHN and cardiac surgery in the EU in 2001. LungFit has several advantages over current standard of care, cylinder based delivery systems, and has the potential for broader use in indications currently being evaluated in two clinical trials. Beyond Air’s market valuation is disconnected from any reasonable estimate of intrinsic value, given the potential for LungFit PH to be launched in the fourth quarter of 2020 in the United States and the potential of its mid-stage clinical pipeline.

Source: Beyond Air February 2020 Corporate Presentation

LungFit PH is a Game Changer for the Treatment of Pulmonary Hypertension

Pulmonary hypertension is currently treated with NO delivered from cylinders. Hospitals that offer cylinder based NO for PH must have the ability to safely store pressurized cylinders, which each weigh about 75 pounds, and also have the ability to purge systems to avoid the buildup of dangerous NO2. Furthermore, a typical NO cylinder delivery system includes two cylinders and a cart that collectively weigh approximately 175 pounds. In addition to the requirements imposed on hospitals, the providers of NO cylinder based systems, Mallinckrodt (MNK) and Praxair, a wholly owned subsidiary of Linde plc (LIN), are required to have extensive and costly service networks to refill and deliver cylinders.

The NO for PH market is currently dominated by Mallinckrodt’s INOmax, which was acquired from Ikaria for $2.3 billion in 2015. According to Mallinckrodt’s public financial filings, sales of INOmax for the 12-month period ending Sept. 30, 2019 were $567 million.

Beyond Air’s LungFit produces

This article was written by

Revere Investing profile picture
Long only equity investor

Analyst’s Disclosure: I am/we are long XAIR.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Comments (13)

I don't know if was you or Seeking Alpha - pulls other negative articles on rocket stocks? I passed on it at $8 because- author said unlikely hospitals would switch out on the basis of no cylinders alone.
Jannik Reiners profile picture
Unfortunate timing lol. LONG XAIR!
Don’t ever fall for SA traps.. they are always epic pump and dump.. always sell half off before events and take profits.. 90 % u will be correct betting again SA advise..
HaroldRamis profile picture
where you been? been telling folks this for YEARS
Revere Investing profile picture
What about the report did you think was pumping?
HaroldRamis profile picture
its not the pumping, but the dumping

twas killed the princess
Milford55 profile picture
Added at 8$, was waiting for this dip. In May 2021, this will be over 50$, some one mark this message.
Created an account just to say woooooow...
A well-executed PUMP AND DUMP lol.
there are several guys on twitter who were pumping this stock for some time. they got what they want. dumped the shares on gullible investors.
HaroldRamis profile picture
SA is the best !!!

for a fade

epic carnage for anyone who took this bait
Nitric Oxide may be only immediate hope to slow COVID-19 as Nitric Oxide has since been shown to be very safe at 160ppm and shows antiviral activity in SARS, which was a different strain of coronavirus. Since vaccines/therapeutics now in development may take months or years before proven safe and effective, NO is best and maybe only option for this COVID-19 season. NO is available now at more than 800 hospitals in the US, and while therapy is limited to these locations and ability to supply NO cylinders, Beyond Air’s generator is portable and generates NO from the air, and can deliver NO anywhere in the world with limitless supply. Also, seems perfect for quarantined patients with limited interaction with technicians. Unlike other coronavirus plays, seems like XAIR has very big, mid to late stage pipeline that just about to have a series of catalysts.
You seem to completely understand this product. Nitric oxide does not slow COVID-19. It is a tool used in the ICU, as the hail mary of icu drugs, if a patient is dying of respiratory failure. This may (or may not) be effective with respect to certain COVID-19 cases that become acute, but from what we are seeing now, very few of these cases are making to the ICU, and even if they do, there's no guarantee this will need to be used.

As has been seen, the vast majority of patients don't seem to be getting that sick. Its the type of thing that gets thrown in when someone on a ventilator is circling the drain, and depending on the circumstance, it can make things worse.

I advise you to reconsider your thesis, since you clearly misunderstand the product and its potential implications with respect to COVID-19.
Disagree with this article? Submit your own. To report a factual error in this article, . Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.